It was recently demonstrated through in vivo and in vitro studies that miR-873 can be biologically significant in paclitaxel and cisplatin resistance in ovarian cancer cell lines where it can directly bind to MRP1 (182). This evidence concerns the gene ABCC1 and ovarian cancer.